Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesDoseology Sciences Inc

Doseology Sciences Inc

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
0.1 CAD 0.01 ( 17.65%)
Last update at 2026-11-06T15:09:00Z
VOLUME
5000
Market Cap
4.97M

Momentum Score

…

Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in January 2020. Doseology Sciences Inc. was incorporated in 2019 and is based in Kelowna, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.10
Low
0.10
High
52 Week Price Range
0.16
Low
1.90
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Doseology Sciences Inc (MOOD.CN) is limited and filings provide minimal operational detail. The company appears to be an early-stage life sciences issuer that may depend on R&D progress, intellectual property and strategic partnerships as long-term growth drivers. Some investors may find exposure to potential therapeutic or tech upside attractive, but that depends on execution of development milestones.
Material risks include limited disclosure and operating history, clinical and regulatory execution risk, need for external financing and low liquidity of a small-cap listing.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.09
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-
ROE
-
Net Debt
-
ROCE
-33.74%
Diluted EPS TTM
-0.14

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -0.45M -0.34M -1.78M -1.94M -1.63M
Net income -0.45M -0.34M -1.78M -1.94M -1.63M
Selling general administrative 0.43M 0.35M 0.68M 1.00M 0.69M
Gross profit 0.02M 0.07M 0.04M -0.15M 0.00M
Reconciled depreciation 0.00M 0.02M 0.07M 0.14M 0.09M
Operating income -0.47M -0.38M -0.83M -1.82M -1.57M
Interest expense - 0.00M 0.04M 0.08M 0.07M
Interest income 0.02M 0.03M 0.07M 0.01M 0.00M
Net interest income 0.02M 0.03M 0.03M -0.07M -0.07M
Total revenue 0.04M 0.10M 0.04M 0.02M 0.00M
Total operating expenses 0.51M 0.48M 0.88M 1.83M 1.57M
Cost of revenue 0.02M 0.03M 0.00M 0.16M 0.00M
Total other income expense net - 0.01M -0.98M -0.05M 0.01M
Net income from continuing ops -0.45M -0.34M -1.78M -1.94M -1.63M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 1.49M 1.10M 1.40M 3.87M 5.99M
Intangible assets - - - 0.01M 0.08M
Other current assets - - - - -0.00M
Total liab 0.09M 0.08M 0.10M 0.87M 3.41M
Total stockholder equity 1.40M 1.02M 1.30M 3.00M 2.58M
Other current liab - - - - 2.31M
Capital stock 7.50M 6.75M 6.71M 6.71M 4.53M
Retained earnings -6.57M -6.12M -5.78M -4.00M -2.06M
Cash 1.43M 1.06M 1.30M 1.87M 3.73M
Total current liabilities 0.09M 0.08M 0.09M 0.22M 2.75M
Total current assets 1.49M 1.10M 1.34M 2.97M 5.00M
Net receivables 0.02M 0.00M 0.00M 0.01M 0.00M
Inventory 0.02M 0.04M 0.01M 0.01M 0.13M
Accounts payable 0.04M 0.05M 0.02M 0.09M 0.06M
Non current assets total 0.00M 0.00M 0.06M 0.90M 0.99M
Capital lease obligations - 0.00M 0.05M 0.75M 0.69M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - - 0.00M 0.00M -0.03M
Net borrowings 0.00M -0.01M -0.09M -0.12M -
Total cash from financing activities 0.71M -0.01M -0.09M -0.14M 5.79M
Net income -0.45M -0.34M -1.78M -1.94M -1.63M
Change in cash 0.37M -0.24M -0.57M -1.86M 3.39M
Begin period cash flow 1.06M 1.30M 1.87M 3.73M 0.34M
End period cash flow 1.43M 1.06M 1.30M 1.87M 3.73M
Total cash from operating activities -0.34M -0.24M -0.48M -1.71M -2.37M
Issuance of capital stock 0.73M 0.00M - 0.00M 3.84M
Depreciation 0.00M 0.02M 0.07M 0.14M 0.09M
Change to inventory 0.02M -0.03M 0.00M -0.04M -0.13M
Sale purchase of stock - - - 0.00M -0.28M
Capital expenditures 0.00M 0.00M 0.00M 0.01M 0.17M
Change in working capital -0.01M 0.03M 0.14M -0.28M -0.92M
Stock based compensation 0.10M 0.02M 0.08M 0.09M 0.02M
Other non cash items 0.02M 0.03M 0.75M 0.08M 0.07M
Free cash flow -0.34M -0.24M -0.48M -1.72M -2.54M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MOOD
Doseology Sciences Inc		 0.01
17.65%		 0.10 - - 50.45 3.77 53.50 -1.30
DRUG
Bright Minds Biosciences Inc		 -0.11
0.42%		 26.00 - - - 13.50 - -0.10
METX
ME Therapeutics Holdings Inc.		 -
-%		 1.05 - - - 72.00 - -
TELI
Telescope Innovations Corp.		 -0.01
1.59%		 0.31 - - 4.32 6.45 4.32 -1.62
DTC
Defence Therapeutics Inc		 0.01
1.43%		 0.35 - - - 89.80 - -9.99

Profile*

Doseology Sciences Inc

Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in January 2020. Doseology Sciences Inc. was incorporated in 2019 and is based in Kelowna, Canada.

9-3151 Lakeshore Road, Kelowna, BC, Canada, V1W 3S9

604-908-3095

https://doseology.com

Name Title Year Born
Ms. Lindsay Hamelin Corporate Secretary NA
Mr. Christopher Jackson CEO & Director 1970
Mr. Timothy Corkum President & COO 1973
Mr. Daniel Vice Co-Founder & Independent Director NA
Mr. Christopher P. Cherry Chief Financial Officer NA
Mr. Lawrence Latowsky Executive Chairman of the Board 1961

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…